Throughout the week, we’ll be looking at how financial advice firms are using, and can use, artificial intelligence (AI) in ...
Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results